Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.
Company profile
Latest filings (excl ownership)
424B3
Prospectus supplement
7 Nov 23
424B3
Prospectus supplement
14 Jul 23
424B3
Prospectus supplement
5 Jul 23
424B3
Prospectus supplement
27 Jul 22
424B3
Prospectus supplement
27 Oct 21
424B3
Prospectus supplement
16 Sep 21
424B3
Prospectus supplement
16 Oct 19
EFFECT
Notice of effectiveness
29 Jul 16
F-6
Registration for ADRs (foreign)
26 Jul 16
Latest ownership filings
No filings